Single Patient Protocol for an NRG1 Fusion Positive Metastatic Pancreatic Cancer Patient Using Seribantumab
Clinical trial NCT04790695 · COMPLETED
Trial details
- NCT number
- NCT04790695
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2021-12-22
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.